OnRamp Bio Debuts as ROSALIND at AGBT and Launches First-of-its-Kind Single Cell Data Analysis Solution

▤ Summary

Formerly known as OnRamp Bio, ROSALIND also unveiled its new corporate brand as part of its presence at the virtual Advances in Genome Biology and Technology (AGBT) conference taking place March 1-3, 2021. “In recent years, enabled by the broad adoption of powerful new technology platforms, single cell analysis has begun to revolutionize biological understanding and translational applications. However, many researchers are encountering challenges with the computational burdens of basic single-cell analysis and a lack of intuitive bioinformatics tools,” said Jean Lozach, Chief Science Officer at ROSALIND. “The company was founded to simplify the practice of data interpretation so that any biologist, researcher or drug developer, no matter their level of bioinformatics expertise, could harness the potential of genomic information. The ROSALIND platform harnesses the power of scientific collaboration, cloud-computing, and data science, to enable integrated analyses that unify knowledge through an intuitive user interface that is built for any researcher.

▦ Linked Companies

Onramp BioInformatics

$1M to $5M